Annalisa Petrelli

2.6k total citations
26 papers, 2.1k citations indexed

About

Annalisa Petrelli is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Annalisa Petrelli has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Annalisa Petrelli's work include MicroRNA in disease regulation (8 papers), Liver physiology and pathology (5 papers) and HER2/EGFR in Cancer Research (5 papers). Annalisa Petrelli is often cited by papers focused on MicroRNA in disease regulation (8 papers), Liver physiology and pathology (5 papers) and HER2/EGFR in Cancer Research (5 papers). Annalisa Petrelli collaborates with scholars based in Italy, United States and Switzerland. Annalisa Petrelli's co-authors include Silvia Giordano, Paolo M. Comoglio, Nicola Migone, Giorgio F. Gilestro, Stefania Lanzardo, Giorgio Valabrega, Cristina Migliore, Amedeo Columbano, Elena Ghiso and Andrea Perra and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Annalisa Petrelli

25 papers receiving 2.1k citations

Peers

Countries citing papers authored by Annalisa Petrelli

Since Specialization

Citations

This map shows the geographic impact of Annalisa Petrelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annalisa Petrelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annalisa Petrelli more than expected).

Fields of papers citing papers by Annalisa Petrelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annalisa Petrelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annalisa Petrelli. The network helps show where Annalisa Petrelli may publish in the future.

Co-authorship network of co-authors of Annalisa Petrelli

This figure shows the co-authorship network connecting the top 25 collaborators of Annalisa Petrelli. A scholar is included among the top collaborators of Annalisa Petrelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annalisa Petrelli. Annalisa Petrelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genome editing of a recalcitrant wine grape genotype by lipofectamine‐mediated delivery of CRISPR/Cas9 ribonucleoproteins to protoplasts 2024 ·The Plant Journal ·Giorgio Gambino, (unknown), (unknown), Walter Chitarra, Chiara Pagliarani, Annalisa Petrelli, Paolo Boccacci, (unknown), Riccardo Velasco, Luca Nerva, Irene Perrone	10
2	Identification of a subpopulation of patients with gastric cancer responsive to PARP inhibitors. 2023 ·Journal of Clinical Oncology ·Simona Corso, Annalisa Petrelli, Sabrina Rizzolio, Filippo Pietrantonio, Sara E. Bellomo, Matteo Benelli, Loris De Cecco, Dario Romagnoli, Violeta Serra, Benedetta Pellegrino, Silvia Giordano	0
3	The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients 2022 ·Cells ·Enrico Berrino, Umberto Miglio, Sara E. Bellomo, (unknown), Alberto Bragoni, Annalisa Petrelli, Eliano Cascardi, Silvia Giordano, Filippo Montemurro, Caterina Marchiò, Tiziana Venesio, Anna Sapino	2
4	Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 2020 ·Journal of Hepatology ·Marta Anna Kowalik, (unknown), Lavinia Cabras, Pia Sulas, Annalisa Petrelli, Andrea Perra, Giovanna M. Ledda‐Columbano, Andrea Morandi, Simone Merlin, (unknown), Carlos Sànchez‐Martìn, Francesca Fornari, Laura Gramantieri, Matteo Parri, Andrea Rasola, Sara E. Bellomo, Carlos Sebastián, Antonia Follenzi, Silvia Giordano, Amedeo Columbano	49
5	MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer 2020 ·ESMO Open ·Annalisa Petrelli, Sara E. Bellomo, Ivana Sarotto, Franziska Kubatzki, Paola Sgandurra, Furio Maggiorotto, (unknown), Riccardo Ponzone, Elena Geuna, Danilo Galizia, (unknown), Enzo Médico, Umberto Miglio, Enrico Berrino, Tiziana Venesio, (unknown), Paolo Provero, Anna Sapino, Silvia Giordano, Filippo Montemurro	12
6	YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC 2017 ·Neoplasia ·Elena Ghiso, Cristina Migliore, (unknown), (unknown), Annalisa Petrelli, Simona Corso, Emmanuele De Luca, G. Gatti, Marco Volante, Silvia Giordano	76
7	The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 2015 ·Journal of Hepatology ·Sandra Mattu, Francesca Fornari, Luca Quagliata, Andrea Perra, Maria Maddalena Angioni, Annalisa Petrelli, Silvia Menegon, Andrea Morandi, Paola Chiarugi, Giovanna M. Ledda‐Columbano, Laura Gramantieri, Luigi Terracciano, Silvia Giordano, Amedeo Columbano	32
8	By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy 2014 ·OncoTargets and Therapy ·Giorgio Stassi, Adriana Cordova, Matilde Todaro, (unknown), Laura Rosa Mangiapane, Annalisa Petrelli, Daniela Taverna, Maria Grazia Daidone, Silvia Giordano, Maurizio Callari, Marilisa Cargnelutti, Filippo Montemurro, Daniela Cimino	1
9	MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC) 2013 ·Hepatology ·Annalisa Petrelli, Andrea Perra, Davide Corà, Pia Sulas, Silvia Menegon, Claudia Manca, Cristina Migliore, Marta Anna Kowalik, Giovanna M. Ledda‐Columbano, Silvia Giordano, Amedeo Columbano	100
10	The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments 2012 ·Molecular Biology of the Cell ·Katia Cortese, Mark T. Howes, Richard Lundmark, Erica Tagliatti, Paola Bagnato, Annalisa Petrelli, Marı́a Rosa Bono, Harvey T. McMahon, Robert G. Parton, Carlo Tacchetti	41
11	Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression 2012 ·Oncogene ·Annalisa Petrelli, Andrea Perra, Katharina Schernhuber, Marilisa Cargnelutti, Alessandro Salvi, Cristina Migliore, Elena Ghiso, A. Benetti, Sergio Barlati, Amedeo Columbano, Nazario Portolani, Giuseppina De Petro, Silvia Giordano	65
12	MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer 2011 ·Clinical Cancer Research ·Cristina Migliore, Valentina Martín, Vera P. Leoni, Angelo Restivo, Luigi Atzori, Annalisa Petrelli, Claudio Isella, Luigi Zorcolo, Ivana Sarotto, G. Casula, Paolo M. Comoglio, Amedeo Columbano, Silvia Giordano	98
13	HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib 2010 ·Breast Cancer Research and Treatment ·Giorgio Valabrega, (unknown), Giuliana Cavalloni, Gianluca Zaccarello, Annalisa Petrelli, Giorgia Migliardi, Andrea Milani, Caterina Peraldo‐Neia, Loretta Gammaitoni, Anna Sapino, Carla Pecchioni, Aldo Moggio, Silvia Giordano, Massimo Aglietta, Filippo Montemurro	35
14	Multitarget drugs: the present and the future of cancer therapy 2009 ·Expert Opinion on Pharmacotherapy ·Annalisa Petrelli, Giorgio Valabrega	73
15	Down-Regulation of the Met Receptor Tyrosine Kinase by Presenilin-dependent Regulated Intramembrane Proteolysis 2009 ·Molecular Biology of the Cell ·Bénédicte Foveau, (unknown), Catherine Leroy, Annalisa Petrelli, Karina Reiß, Valérie Vingtdeux, Silvia Giordano, Véronique Fafeur, David Tulasne	87
16	MicroRNAs Impair MET-Mediated Invasive Growth 2008 ·Cancer Research ·Cristina Migliore, Annalisa Petrelli, Elena Ghiso, Simona Corso, Lorena Capparuccia, Adriana Eramo, Paolo M. Comoglio, Silvia Giordano	146
17	From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage 2008 ·Current Medicinal Chemistry ·Silvia Giordano, Annalisa Petrelli	365
18	TGFα expression impairs Trastuzumab-induced HER2 downregulation 2005 ·Oncogene ·Giorgio Valabrega, Filippo Montemurro, Ivana Sarotto, Annalisa Petrelli, Patrizia Rubini, Carlo Tacchetti, Massimo Aglietta, Paolo M. Comoglio, Silvia Giordano	113
19	The endophilin–CIN85–Cbl complex mediates ligand-dependent downregulation of c-Met 2002 ·Nature ·Annalisa Petrelli, Giorgio F. Gilestro, Stefania Lanzardo, Paolo M. Comoglio, Nicola Migone, Silvia Giordano	373
20	The SH3 Domains of Endophilin and Amphiphysin Bind to the Proline-rich Region of Synaptojanin 1 at Distinct Sites That Display an Unconventional Binding Specificity 1999 ·Journal of Biological Chemistry ·Gianluca Cestra, Luisa Castagnoli, Luciana Dente, Olga Minenkova, Annalisa Petrelli, Nicola Migone, Ulrich Hoffmüller, Jens Schneider‐Mergener, Gianni Cesareni	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact